Sandbox Clinical Ventures Fund, LP
213 · adviser of record: 213 Management, LLC · 2023 vintage
Sandbox Clinical Ventures Fund, LP is a 2023 venture fund managed by 213, with $72mm raised (Form D, amount sold). It reported $74.7mm in gross assets at year-end 2025, 1.04x its size, its highest reported value.
- Latest value held
- $74.7mm year-end 2025
- Peak
- $74.7mm year-end 2025
- Fund size
- $72mm Form D, amount sold
- Held vs. size
- 1.04x peak 1.04x
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2025 | $74.7mm | 1.04x | +31% over 2 yrs |
| 2023 | $57.1mm | 0.79x | – |
Other funds from 213
- Bluecross Blueshield Venture Partners V, LLC 2022
- Sandbox Insurtech Fund II, LP 2021
- Bluecross Blueshield Venture Partners IV, LLC 2020
- Sandbox Insurtech Fund, LP 2018
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-2067917514. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.